期刊文献+

卡维地洛治疗充血性心力衰竭合并快速型心房纤颤的疗效观察 被引量:1

Effects of carvedilol on patients with congestive heart failure and atria fibrillations
下载PDF
导出
摘要 目的 观察卡维地洛治疗充血性心力衰竭 (CHF)合并快速型心房纤颤 (Af)的临床疗效。方法 将CHF并快速型Af患者 5 6例 ,随机分为治疗组、对照组各 2 8例。治疗组在常规治疗的基础上加用卡维地洛。对照组给予强心利尿等常规治疗。疗程均为 16周。结果 治疗组在临床疗效 (92 .86 % )、心电图疗效 (85 .72 % )以及心泵功能各项指标均明显优于对照组 (P <0 .0 1)。结论 卡维地洛治疗CHF并快速型Af,既能有效控制心室率 ,又能显著改善心功能。 Objective To evaluate the effects of carvedilol on patients with congestive heart failure(CHF) and rapid atria fibrillation(Af). Methods Fifty-six patients with CHE and rapid Af were randomly divided into two groups. The patients of control group(28 cases) received routine treatment(diuretic, cardiac glycoside, etc.) The observation group(28 cases) was added with carvedilol. The whole course lasted for sixteen weeks.Results After treatment, the clinical efficiencies and electrocardiogram efficiencies in the observation group were 92.86% and 85.72%. It was clear better than routine treatment(P<0.01).Conclusion Carvedilol is effective and safe in the treatment of congestive heart failure and rapid atria fibrillation. It can both efficiently control heart rate and greatly improve cardiac function.
出处 《医师进修杂志》 北大核心 2004年第1期26-28,共3页 Journal of Postgraduates of Medicine
关键词 卡维地洛 充血性心力衰竭 快速型心房纤颤 药物治疗 合并症 carvedilol congestive heart failure rapid atria fibrillation
  • 相关文献

参考文献4

二级参考文献32

  • 1[1]Denniss AR,March JD,Quigg RT,et al. β-adrenergic receptor member and adenylate cyclase function in denervanted transplanted and cardiomyopathic humen heart[ J ]. Circulation, 1989,79:1028.
  • 2[2]Simko F, Simko J. Heart failure and angiotensin converting enzyme inhibition:problems and prospects [J]. Physiol Res, 1999,48 ( 1 ): 1-8.
  • 3[3]Bristow M R. Carvedilol treatment of chronic heart failure: a new era [J]. Heart,1998,79(2) :8.
  • 4[4]Bristow MR. Mechanism of action of beta-blocking agents in heart failure [J].Am J Cardiol,1997,80(11A) :26.
  • 5[5]Gilbert EM, Abraham WT,Olsen S,et al. Comparative hemodynanic,left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart [ J ]. Circulation, 1996.94:2817.
  • 6[6]Stoschitzky K,Koshucharova G,Zweiker R,et al. Differing beta-blocking effects of carvedilol and metoprolol [ J ]. Heart Failure 2001,3 ( 3 ) :343-349.
  • 7[7]Packer M, Antonopoulos GV, Berlin JA, et al. Comparative effects of carvedilol and metoprolol on left ventricular ejection fration in heart fail:results of a metaanalysis[J]. Heart,2001,141 (6) :899-907.
  • 8[8]Atumanayagam M ,Chan S,Tong S. et al. Antioxidaot peoperties of carvedilol and metoprolol in heart failure:a double-blind randomized controlled trial, [J]. Cardiovasc pharmacol,2001,37( 1 ) :48-54.
  • 9[9]Packer M, Bristow RW, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure [J]. N Engl J Med, 1996,334:1349-1355.
  • 10[10]Bristow MR,Gilbert EM,Abrahan WT,et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure [ J ]. Circulation, 1996,94: 2708 -2716.

共引文献27

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部